Genentech Avastin Supply Will Come From Two Sites; BLA Coming Soon

Commercial supply for Genentech's vascular endothelial growth factor inhibitor Avastin could come from two manufacturing facilities, Chief Medical Officer Susan Hellmann, MD, said during an investor conference call July 9